Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms. - Wikidata - awgldk - TriplyDB

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

http://www.wikidata.org/entity/Q35763180

about

Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson Disease Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift In vivo human apolipoprotein E isoform fractional turnover rates in the CNS Apolipoprotein E isoform-specific effects on lipoprotein receptor processing.Retinoic acid isomers facilitate apolipoprotein E production and lipidation in astrocytes through the retinoid X receptor/retinoic acid receptor pathway.The role of apolipoprotein E in Alzheimer's disease.Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.A-Subclass ATP-Binding Cassette Proteins in Brain Lipid Homeostasis and Neurodegeneration.ABC Transporters and the Alzheimer's Disease Enigma.Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.Neurodegeneration and Alzheimer's disease (AD). What Can Proteomics Tell Us About the Alzheimer's Brain?Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.Role of ATP-binding cassette transporters in brain lipid transport and neurological disease.The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration Research Lumbar Punctures among African Americans and Caucasians: Perception Predicts Experience.Peripheral apoE isoform levels in cognitively normal APOE ε3/ε4 individuals are associated with regional gray matter volume and cerebral glucose metabolism.CSF Apo-E levels associate with cognitive decline and MRI changes Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk.ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?Apolipoprotein E, amyloid-beta, and neuroinflammation in Alzheimer's disease ATP-binding cassette transporter A1: from metabolism to neurodegeneration.Effects of ABCA1 R219K Polymorphism and Serum Lipid Profiles on Mild Cognitive Impairment in Type 2 Diabetes Mellitus.Central Nervous System Lipoproteins: ApoE and Regulation of Cholesterol Metabolism.Cerebrospinal fluid apolipoprotein E concentration and severity of cognitive impairment in patients with newly diagnosed Alzheimer's disease.Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain Amyloid-β42 alters apolipoprotein E solubility in brains of mice with five familial AD mutations.The serine protease HtrA1 contributes to the formation of an extracellular 25-kDa apolipoprotein E fragment that stimulates neuritogenesis.Apolipoprotein E levels in the cerebrospinal fluid of north Indian patients with Alzheimer's disease.Quantitative assessment of the effect of ABCA1 gene polymorphism on the risk of Alzheimer's disease.

P2860

Q27314618-D45C5A08-9D6A-4707-AE1B-E464E8222CF8 Q28282855-38D527ED-67F9-4510-84B2-CFF95BA5202F Q28553918-263B36AD-C893-4389-91C9-5217EFAC5679 Q28582464-CF254173-EA37-483F-8C2C-D53BA05E9991 Q28728902-33BB4E66-DC23-4055-B228-370FB9337A3A Q33112703-BA0FEF44-B10C-4D48-A1F7-9A246D382435 Q33676328-24DE8B9A-D717-4D7D-A544-2DFD69E28B18 Q34603092-1EBCA5AD-D12E-4CEB-B707-B22D377953D6 Q35337926-8A5C6A47-2AC6-4B1B-9183-8E5D5C301EEE Q35801008-7A340A4D-8AA3-4C64-ADCD-C911C68A77BD Q36005085-F8A70302-D57D-4D34-82D6-BBD4E6FBE9E6 Q36283394-C24F28EE-8A00-49E5-9362-D8EE2CF432DD Q36539376-273158A9-CCF3-4E66-8A8F-C88E52AE192E Q36539454-68DA346B-D721-47BB-9E0C-5B8D3DE69EC1 Q36822983-89532810-1AB5-4925-995D-EFAEE4A1FFC2 Q36987318-3259ED1D-BA3D-4B4E-9F8F-41BCE75E2C81 Q37017266-34C60746-586A-4B48-A0B4-A83E27CCF647 Q37463657-3ACDED2D-5555-4D3F-8B3E-4C0A1580E230 Q37615967-521AF9B5-9040-4AFF-88D4-50FB8DA48F90 Q37705204-6C46F19C-6F3B-4B2A-B67E-ACC81A71D59F Q38175420-11B3159A-BC6F-4EDD-A0E5-5B009D5749A2 Q38190156-82F46101-7DD4-4C4D-A201-E9D26E042B2B Q38197948-58526D2D-B2A9-422C-B210-C436D35F370B Q38213077-3528C632-3930-4902-86C2-9027BAB87B06 Q38616803-8C5D2261-A330-47AF-9937-2BD2DCDC0A84 Q38833309-CE08241B-27D5-42DE-8AB5-48540FDF694A Q39307470-9AC136D5-DF87-43DE-8CD0-3FDBDDB4446F Q41810449-E297896C-60C8-416C-96D9-851C3FE5C6D8 Q42651770-C74118C9-A4B6-405C-AB67-EA5F72CA0255 Q50134122-C671E332-E173-479C-9179-61FB2C5C5043 Q51047459-56CA67D6-5596-415E-8CE2-16131C950674 Q53334126-8B7F4C54-AA25-472B-8DA1-5A0DFBF306DA

P2860

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

http://www.wikidata.org/entity/Q35763180

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@ast

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@en

type

label

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@ast

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@en

prefLabel

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@ast

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@en

P1433

Q35763180-310FDF88-9BB1-4312-8F20-DB925CD3CCAA

P1476

Q35763180-FC134E8B-D93C-40E5-9A7E-BD6A87970434

P2093

Q35763180-1F1B86E1-FC45-46DC-9F47-14EC6DC4BFAE

Q35763180-81B99A48-F417-4CFE-AFE2-9423975218F3

Q35763180-A76DE910-F42D-4161-AC59-0DEDE2BEAF8B

Q35763180-C9FBC7B8-C0CE-4D79-BB23-1F19E3194B41

Q35763180-D7F4C174-7088-496A-9C97-E42E005ED8DE

Q35763180-D8A5CC5B-F3E9-4570-B2D7-A52E73CA7EB4

Q35763180-E482FAA8-3DBC-4F8A-A798-C6304CD8363C

Q35763180-F570D9E3-85DC-40FE-9A09-D7F95DC5DEF3

Q35763180-F59140D2-5346-4E46-938D-D2C4E113B9E2

P2860

Q35763180-00251FBF-14B3-4B50-80DE-52B72BA54AA7

Q35763180-00EA5188-1689-479C-9B3A-F32966A09FC6

Q35763180-01CB2DE3-2D27-4CCC-ABAB-970A49DD47BC

Q35763180-042E8094-5896-4BD9-B61E-1AD857F85186

Q35763180-0C21A2CD-A880-4C50-A249-C61DD081B391

Q35763180-1019246E-D83E-4310-8709-FDFA00F59C20

Q35763180-184DE2B6-3C51-439B-ACEB-A7C8AFC82E72

Q35763180-1C9EF8B1-307D-4C53-ABB8-85FC165F2541

Q35763180-1DFD3A82-6622-46ED-BF15-79BD2A484892

Q35763180-2331F202-58FB-480A-A09E-A92F19D4C251

P2888

Q35763180-A043E552-19DF-4738-A4F1-99C41C30A7AD

P304

Q35763180-99E86B9C-8D88-48B6-905F-C93AEAFAC39D

P31

Q35763180-9539F80F-6D69-48F6-85C6-7E3F6D9F893D

P356

Q35763180-E4BCCD8F-F196-419F-B3A6-FF74AE92F698

P478

Q35763180-4B175F5C-C175-4F37-9B86-D96179591845

P50

Q35763180-44A22756-BF00-4CC3-B962-CFB73F4BA02D

Q35763180-D47E2195-FF54-4DEA-83F8-91BAAD07D314

Q35763180-F9F24756-B3DA-4047-973C-398554AE99E6

P577

Q35763180-422943AA-34B9-490E-A83A-5543A79A88C9

P5875

Q35763180-7EDB04D0-3188-4D3D-8D03-BFE6C5878419

P6179

Q35763180-E6857613-F79D-4FAC-A5B7-46F30B5614DC

P698

Q35763180-97AA67A3-7978-4D67-A073-A7FC959C609E

P921

Q35763180-06592FDB-83BF-4373-B294-CC22499B5862

P932

Q35763180-045FFE75-38A8-44FD-96E6-6452503F6E1F

P356

P1433

Molecular Neurodegeneration

P1476

Apolipoprotein E levels in cerebrospinal fluid and the effects of ABCA1 polymorphisms.

@en

P2093

Aarti R Shah

http://www.w3.org/2001/XMLSchema#string

Andrew Grupe

http://www.w3.org/2001/XMLSchema#string

Anthony Hinrichs

http://www.w3.org/2001/XMLSchema#string

Hong Jiang

http://www.w3.org/2001/XMLSchema#string

John S K Kauwe

http://www.w3.org/2001/XMLSchema#string

Kevin Mayo

http://www.w3.org/2001/XMLSchema#string

Leon J Thal

http://www.w3.org/2001/XMLSchema#string

Scott Smemo

http://www.w3.org/2001/XMLSchema#string

Suzanne E Wahrle

http://www.w3.org/2001/XMLSchema#string

P2860

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

APOE genotype is a major predictor of long-term progression of disability in MS

Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury

Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain

Screening for functional sequence variations and mutations in ABCA1.

Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease.

Ordered-subsets linkage analysis detects novel Alzheimer disease loci on chromosomes 2q34 and 15q22.

P2888

P304

7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1326-2-7

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

David M. Holtzman

P577

2007-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6397083

http://www.w3.org/2001/XMLSchema#string

P6179

1018463350

http://www.w3.org/2001/XMLSchema#string

P698

17430597

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

1857699

http://www.w3.org/2001/XMLSchema#string